The Top Biosimilars Interviews of 2017

Article

2017 brought a number of notable guests to The Center for Biosimilars®. Here are the most-watched interviews of the year.

2017 brought a number of notable guests to The Center for Biosimilars®. Below are the most-watched interviews of the year:

Number 5: Marcus H. Snow, MD, Assistant Professor Rheumatology, University of Nebraska, discusses the recent launch of a new biosimilar infliximab, Renflexis, in the United States.

Number 4: Brandon Shank, PharmD, MPH, BCOP, Clinical Pharmacy Specialist, discusses the importance of pharmacist education on biosimilar treatments.

Number 3: Joseph Fuhr, PhD, explains why biosimilars could bring on brand-to-brand competition.

Number 2: Angus Worthing, MD, FACR, FACP, discusses the benefits of biosimilar medicines.

Number 1: Ha Kung Wong, JD, Partner at Fitzpatrick, Cella, Harper and Scinto, discusses incentives for biosimilar applicants to engage in the BPCIA "patent dance" after the Supreme Court's ruling in Sandoz v Amgen.

Related Videos
Fran Gregory, PharmD, MBA
Julie Reed
Julie Reed, MS
Julie Reed, executive director of the Biosimilars Forum
 Fran Gregory, PharmD, vice president of emerging therapies, Cardinal Health.
Ryan Haumschild, PharmD, MS, MBA
Fran Gregory, PharmD, vice president of emerging therapies, Cardinal Health
Fran Gregory, PharmD, vice president of emerging therapies at Cardinal Health
andre harvin
Here are the top 5 biosimilar articles for the week of May 1, 2023.
Related Content
© 2023 MJH Life Sciences

All rights reserved.